ArticleJournal of hepatocellular carcinoma2025

Lobar Yttrium-90 Radioembolization with BSA-Based Dosimetry for Unresectable Hepatocellular Carcinoma: Baseline Vascularity Predicts Responders to the Combination with Targeted Therapy or Immune Checkpoint Inhibition.

Willie M Lüdemann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.